NRX Pharmaceuticals Q1 EPS $(0.74) Misses $(0.37) Estimate

Benzinga ·  May 14 16:37

NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0.37) by 100 percent. This is a 53.75 percent increase over losses of $(1.60) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment